TLX
Telix Pharmaceuticals Limited
NASDAQ · Healthcare · Biotechnology · AU
$11.95
+1.75%Forward multiples
Based on analyst estimates
- P/E forward
- 89.22x
- P/E 2026E
- 155.80x
- P/E 2027E
- 228.59x
- P/E 2028E
- 48.02x
- P/S forward
- 8.09x
Trailing multiples
Trailing twelve months
- P/E TTM
- 66.82x
- PEG TTM
- —
- Price / book
- 7.98x
- Price / sales
- 2.25x
- Price / cash flow
- 479.18x
Enterprise value
- Enterprise value
- $4.4B
- EV / sales
- 2.44x
- EV / EBITDA
- 44.19x
- EV / EBIT
- 82.26x
- Market cap
- $4.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026